The evidences include: overexpression of MCM2 in gastric tumors predicted poor prognosis in the patients [39]; knock down of HJURP reduced the sensitivity of breast cancer patients to radiation treatment [40]; the loss of CHD8 may be an indicator for biological aggressiveness in gastric cancer [41]. Here, MCM2 is linked to gastric neoplasm.